SGN-CD352A: A novel humanized anti-CD352 antibody -drug conjugate for the treatment of multiple myeloma

被引：10
|
作者：
Lewis, Tim
Olson, Devra J.
Gordon, Kristine A.
Sandal, Sharsti L.
Miyamoto, Jamie
VVestendorf, Lori
Linares, Germein
Leiske, Chris
Kostner, Heather
Stone, Ivan
Anderson, Martha
Nesterova, Albina
Jonas, Mechthild
Law, Che-Leung
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1195
引用
收藏
页数：3
相关论文
共 50 条
  • [41] An Immune Based, Anti-CD138 Targeting Antibody for the Treatment of Multiple Myeloma
    Yu, Tengteng
    Xing, Lijie
    Lin, Liang
    Liu, Jiye
    Wen, Kenneth
    Cho, Shih-Feng
    Hsieh, Phillip
    Myette, James
    Chaganty, Bharat
    Adari, Hedy
    Tissire, Hamid
    Deotale, Ketan
    Shriver, Zach
    Munshi, Nikhil
    Tai, Yu-Tzu
    Anderson, Kenneth
    BLOOD, 2018, 132
  • [42] Specific tumor targeting and potent bystander killing with SGN-35, an anti-CD30 antibody drug conjugate.
    Okeley, Nicole M.
    Alley, Stephen C.
    Cerveny, Charles G.
    Andreyka, Jamie
    Sanderson, Russell J.
    Anderson, Martha
    Benjamin, Dennis R.
    Law, Che-Leung
    Sievers, Eric
    Ihle, Nathan C.
    BLOOD, 2006, 108 (11) : 72A - 72A
  • [43] Characterization of SGN-CD123A, APotent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia
    Li, Fu
    Sutherland, May Kung
    Yu, Changpu
    Walter, Roland B.
    Westendorf, Lori
    Valliere-Douglass, John
    Pan, Lucy
    Cronkite, Ashley
    Sussman, Django
    Klussman, Kerry
    Ulrich, Michelle
    Anderson, Martha E.
    Stone, Ivan J.
    Zeng, Weiping
    Jonas, Mechthild
    Lewis, Timothy S.
    Goswami, Maitrayee
    Wang, Sa A.
    Senter, Peter D.
    Law, Che-Leung
    Feldman, Eric J.
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 554 - 564
  • [44] Novel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL)
    Yokota, Riri
    Hashimoto, Shun
    Watanabe, Ikuko
    Kishimoto, Satoshi
    Toyama, Masaaki
    Okamoto, Mika
    Yoshimitsu, Makoto
    Ishitsuka, Kenji
    Ito, Yuji
    Baba, Masanori
    ANTICANCER RESEARCH, 2020, 40 (08) : 4471 - 4479
  • [45] Model-based alternative clinical trial designs and evaluations for SGN-CD19A, a novel antibody-drug conjugate
    Zhao, Baiteng
    Albertson, Tina M.
    Law, Che-Leung
    O'Meara, Megan M.
    Kostic, Ana
    Han, Tae H.
    CANCER RESEARCH, 2014, 74 (19)
  • [46] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Stanchina, Michele
    Pastore, Alessandro
    Devlin, Sean
    Famulare, Christopher
    Stein, Eytan
    Taylor, Justin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [47] In the spotlight: a novel CD37 antibody-drug conjugate
    Palomba, M. Lia
    Younes, Anas
    BLOOD, 2013, 122 (20) : 3397 - 3398
  • [48] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [49] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Michele Stanchina
    Alessandro Pastore
    Sean Devlin
    Christopher Famulare
    Eytan Stein
    Justin Taylor
    Journal of Hematology & Oncology, 12
  • [50] The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody-drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
    Egan, Pamela C.
    Reagan, John L.
    ONCOTARGETS AND THERAPY, 2018, 11 : 8265 - 8272
12345